203 related articles for article (PubMed ID: 31099477)
1. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
Grilz E; Marosi C; Königsbrügge O; Riedl J; Posch F; Lamm W; Lang IM; Pabinger I; Ay C
J Thromb Haemost; 2019 Aug; 17(8):1335-1344. PubMed ID: 31099477
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
3. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
4. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
7. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
[TBL] [Abstract][Full Text] [Related]
8. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb.
Gremmel T; Ay C; Seidinger D; Pabinger I; Panzer S; Koppensteiner R
J Vasc Surg; 2011 Dec; 54(6 Suppl):48S-55S. PubMed ID: 21890302
[TBL] [Abstract][Full Text] [Related]
9. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
Grilz E; Posch F; Königsbrügge O; Schwarzinger I; Lang IM; Marosi C; Pabinger I; Ay C
Thromb Haemost; 2018 Nov; 118(11):1875-1884. PubMed ID: 30296815
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Value of d-Dimer, P-Selectin, and Platelet Count for Prediction of Portal Vein Thrombosis After Devascularization.
Fei Y; Zong GQ; Chen J; Liu RM
Clin Appl Thromb Hemost; 2016 Jul; 22(5):471-5. PubMed ID: 25633343
[TBL] [Abstract][Full Text] [Related]
12. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
[TBL] [Abstract][Full Text] [Related]
13. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I
Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899
[TBL] [Abstract][Full Text] [Related]
14. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion.
Woollard KJ; Kling D; Kulkarni S; Dart AM; Jackson S; Chin-Dusting J
Circ Res; 2006 Jan; 98(1):149-56. PubMed ID: 16339486
[TBL] [Abstract][Full Text] [Related]
15. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
[TBL] [Abstract][Full Text] [Related]
16. Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study.
Mrozinska S; Wypasek E; Broniatowska E; Undas A
Sci Rep; 2021 Oct; 11(1):21003. PubMed ID: 34702844
[TBL] [Abstract][Full Text] [Related]
17. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
19. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Grilz E; Mauracher LM; Posch F; Königsbrügge O; Zöchbauer-Müller S; Marosi C; Lang I; Pabinger I; Ay C
Br J Haematol; 2019 Jul; 186(2):311-320. PubMed ID: 30968400
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
